He Shao-heng, Chen Han-qiu, Zheng Jian
Allergy and Inflammation Research Institute, Shantou University Medical College, Shantou 515031, China.
Acta Pharmacol Sin. 2004 Dec;25(12):1677-84.
To investigate the ability of proteinase inhibitors to modulate nucleated cell infiltration into the peritoneum of mice induced by tryptase and chymase.
Human lung tryptase and skin chymase were purified by a similar procedure involving high salt extraction, heparin agarose affinity chromatography followed by S-200 Sephacryl gel filtration chromatography. The actions of proteinase inhibitors on tryptase and chymase induced nucleated cell accumulation were examined with a mouse peritoneum model.
A selective chymase inhibitor Z-Ile-Glu-Pro-Phe-CO2Me (ZIGPPF) was able to inhibit approximately 90 % neutrophil, 73 % eosinophil, 87 % lymphocyte and 60 % macrophage accumulation induced by chymase at 16 h following injection. Soy bean trypsin inhibitor (SBTI), chymostatin, and alpha1-antitrypsin showed slightly less potency than ZIGPPF in inhibition of the actions of chymase. While all tryptase inhibitors tested were able to inhibit neutrophil, eosinophil, and macrophage accumulation provoked by tryptase at 16 h following injection, only leupeptin, APC366, and aprotinin were capable of inhibiting tryptase induced lymphocyte accumulation. The inhibitors of tryptase tested were also able to inhibit tryptase induced neutrophil and eosinophil accumulation at 6 h following injection. When being injected alone, all inhibitors of chymase and tryptase at the concentrations tested by themselves had no significant effect on the accumulation of nucleated cells in the peritoneum of mice at both 6 h and 16 h.
Proteinase inhibitors significantly inhibited tryptase and chymase-induced nucleated cell accumulation in vivo, and therefore they are likely to be developed as a novel class of anti-inflammatory drugs.
研究蛋白酶抑制剂调节由类胰蛋白酶和糜蛋白酶诱导的小鼠腹腔有核细胞浸润的能力。
通过类似的程序纯化人肺类胰蛋白酶和皮肤糜蛋白酶,该程序包括高盐提取、肝素琼脂糖亲和层析,随后进行S-200 Sephacryl凝胶过滤层析。用小鼠腹腔模型检测蛋白酶抑制剂对类胰蛋白酶和糜蛋白酶诱导的有核细胞聚集的作用。
一种选择性糜蛋白酶抑制剂Z-Ile-Glu-Pro-Phe-CO2Me(ZIGPPF)在注射后16小时能够抑制由糜蛋白酶诱导的约90%的中性粒细胞、73%的嗜酸性粒细胞、87%的淋巴细胞和60%的巨噬细胞聚集。大豆胰蛋白酶抑制剂(SBTI)、糜蛋白酶抑制剂和α1-抗胰蛋白酶在抑制糜蛋白酶作用方面的效力略低于ZIGPPF。虽然所有测试的类胰蛋白酶抑制剂在注射后16小时都能够抑制由类胰蛋白酶引起的中性粒细胞、嗜酸性粒细胞和巨噬细胞聚集,但只有亮抑酶肽、APC366和抑肽酶能够抑制类胰蛋白酶诱导的淋巴细胞聚集。所测试的类胰蛋白酶抑制剂在注射后6小时也能够抑制类胰蛋白酶诱导的中性粒细胞和嗜酸性粒细胞聚集。当单独注射时,所有测试浓度的糜蛋白酶和类胰蛋白酶抑制剂在6小时和16小时对小鼠腹腔有核细胞的聚集均无显著影响。
蛋白酶抑制剂在体内显著抑制类胰蛋白酶和糜蛋白酶诱导的有核细胞聚集,因此它们有可能被开发成为一类新型抗炎药物。